CVF, LLC

This profile gathers the share dealings of CVF, LLC across 3 companies, led by Cerulean Pharma Inc., Fractyl Health, Inc. and Rein Therapeutics, Inc. We count 10 filings; the first trade dates from 15 April 2014 and the latest from 6 February 2024.

On the market, this insider has only ever bought: 4 purchases, €13.1M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2024 alone, the filings show 1 purchase and no sales.

A typical purchase (the median) is worth €3.3M. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -32.7%. These figures describe past trades and do not predict future prices.

Most recently, on 6 February 2024, the filings show a transaction in Fractyl Health, Inc. The clock since the last published purchase (6 February 2024) now reads 1,006 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.